Roots Analysis has done a detailed study on the Modular Facilities in Pharmaceutical and Biotechnology Market, covering key aspects of the industry and identifying potential future growth opportunities.
To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html
Key Market Insights
§ 30+ companies offer services for the construction of modular facilities; a relatively larger proportion of these firms are headquartered in the US
§ Stakeholders are catering to the needs of various industries, providing services across the globe; in recent years, several small firms / start-ups have been established in this domain
§ Realizing the advantages, many big pharma companies have established modular facilities in the recent past; in addition to capacity expansion, this has allowed them to significantly optimize project cost and timelines
§ The growing interest in this field is evident in the rise in partnership activity in the recent past; in fact, the maximum number of collaborations was reported in 2020
§ Close to 200 industry players claim to offer modular cleanrooms, along with a number of associated services, to the pharmaceutical and biotechnology industries worldwide
§ In addition to shorter construction times, lower financial risks and high internal rate of return are the key advantages offered by modular facilities; experts continue to remain optimistic about proprietary offerings
§ In the foreseeable future, a variety of lucrative opportunity areas are expected to fuel the adoption of modular solutions within pharma and biotech industry; this is also evident from recent trends observed on google news
§ The projected future opportunity is likely to be distributed across firms that offer different types of modules and construction components to serve multi-purpose market demands
§ Modular manufacturing facility related pharmaceutical operations are anticipated to contribute the major share of revenues, especially those dedicated to emerging biologics
§ In the long run, we expect the market to grow at a CAGR of nearly 10%, with majority of the revenues being generated through the establishment of modular facilities in variable sizes in response to industry demand
For more information, please visit https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html
4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
4.1. Chapter Overview
4.2. Modular Facility Manufacturers: Overall Market Landscape
4.2.1 Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Geographical Coverage
4.2.5. Analysis by Geographical Coverage and GMP Compliance
4.2.6. Analysis by Type of Industry Served
4.2.7. Analysis by Geographical Coverage and Type of Industry Served
4.2.8. Historical and Current Market Landscape Trend Analysis
4.2.8.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served
4.2.9. Quality Certifications
4.3. Modular Facility Manufacturers: COVID-19-related Initiatives
Request Sample Pages - https://www.rootsanalysis.com/reports/178/request-sample.html
Download Free Insights now - https://www.rootsanalysis.com/reports/178/free-insights.html
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
You may also be interested in the following titles:
1. Vaccine Contract Manufacturing Market (3rd Edition), 2021-2030
2. Biopharmaceutical CROs Market, 2021-2030
3. Continuous Manufacturing Equipment Providers Market, 2021-2030
4. DNA-Encoded Libraries: Platforms and Services Market
5. Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
Find out why having a modular kitchen makes sense and why should you invest in a modular kitchen.https://haecker-india.com/5-reasons-why-having-a-modular-kitchen-makes-sense
